A prospective study of an algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran's hospital

被引:19
|
作者
Maisel, AS
Templin, K
Love, M
Clopton, P
机构
[1] VAMC Cardiol 111A, Div Cardiol, Dept Med, San Diego, CA 92116 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
关键词
myocardial infarction; troponin; myoglobin;
D O I
10.1002/clc.4960231212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Accurate and cost-effective evaluation of acute chest pain has been problematic fur years. The high prevalence of missed myocardial infarctions (MI) has led to conservative triage behavior on the part of physicians, leading to expensive admissions to coronary cue units. New algorithms are sorely needed for more rapid and accurate triage of patients with chest pain to appropriate treatment settings. Hypothesis: We sought to test an algorithm for rapid diagnosis of MI and acute coronary syndromes using cardiac troponin I (cTnI) and myoglobin as adjuncts to creatine kinase (CK)-MB, We hypothesized our algorithm would be both sensitive and specific at early time points, and would allow safe stratification of patients nut ruling in by conventional CK-MB criteria. Methods: This was a 6-month prospective study of 505 consecutive patients who presented with chest pain at a university-affiliated veteran's hospital. The percentage of MIs at various rime points was identified using combinations of markers. Safely outcomes were assessed by follow-up of patients discharged home, Cost savings analysis was assessed by surveying the physicians as to whether the use of the algorithm affected their disposition of patients. Forty-nine patients ruled in for MI. Using the combination of cTnI, 2-h doubling of myoglobin, and CK-MB, 37 (76%) ruled in at the time of presentation, 43 (88%) at 2 h, and 100% by 6 h. Results: Cardiac troponin I plus a 2-h myoglobin was as accurate as the combination of all three markers and performed better than CK-MB in detecting patients presenting late and as a predictor for complications when CK-MB was normal. Of the 456 patients with normal markers after 6 h, only 140 were sent to the coronary care unit (CCU), and 176 were sent home. A 3-month follow-up showed minimal adverse events. One-half of physicians completing a survey stated the use of markers changed their disposition of patients, leading to an estimated 6-month cost savings of a half-million dollars. Conclusions: We developed an algorithm using troponin I and myoglobin as adjuncts to usual CK-MB levels that allowed for rapid and accurate assessment of patients with acute MI. It also afforded physicians important input into their decision making as to how best to triage patients presenting with chest pain. Their comfort in sending home certain subgroups of patients who otherwise would have been admitted to the CCU was rewarded with a good short-term prognosis and a large cost savings to the hospital.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 50 条
  • [41] Fabrication of Electrochemical Immunosensor for Cardiac Biomarker Troponin I Determination and Its Potential for Acute Myocardial Infarction Diagnosis
    Li, Zhibo
    Ma, Ke
    Cheng, Zhihua
    Yan, Cui
    Liu, Guifeng
    INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE, 2017, 12 (03): : 2389 - 2399
  • [42] Rates of diagnosis of acute myocardial infarction utilizing cardiac troponin-I or creatine kinase MB.
    Lin, JC
    Apple, FS
    Murakami, MM
    Luepker, RV
    CLINICAL CHEMISTRY, 2003, 49 (06) : A62 - A62
  • [43] Early diagnosis of acute myocardial infarction using sensitive cardiac troponin assays in patients with kidney disease
    Twerenbold, R.
    Reiter, M.
    Heinisch, C.
    Reichlin, T.
    Arenja, N.
    Socrates, T.
    Noveanu, M.
    Meissner, J.
    Winkler, K.
    Mueller, C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 649 - 650
  • [44] Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm
    Neumann, Johannes Tobias
    Soerensen, Nils Arne
    Schwemer, Tjark
    Ojeda, Francisco
    Bourry, Rafael
    Sciacca, Vanessa
    Schaefer, Sarina
    Waldeyer, Christoph
    Sinning, Christoph
    Renne, Thomas
    Than, Martin
    Parsonage, William
    Wildi, Karin
    Makarova, Nataliya
    Schnabel, Renate B.
    Landmesser, Ulf
    Mueller, Christian
    Cullen, Louise
    Greenslade, Jaimi
    Zeller, Tanja
    Blankenberg, Stefan
    Karakas, Mahir
    Westermann, Dirk
    JAMA CARDIOLOGY, 2016, 1 (04) : 397 - 404
  • [45] Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A thrombolysis in myocardial infarction (TIMI) 11B substudy
    Morrow, DA
    Rifai, N
    Tanasijevic, MJ
    Wybenga, DR
    De Lemos, JA
    Antman, EM
    CLINICAL CHEMISTRY, 2000, 46 (04) : 453 - 460
  • [46] A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a veteran's hospital: A pilot study
    Roppolo, LP
    Fitzgerald, R
    Dillow, J
    Ziegler, T
    Rice, M
    Maisel, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (02) : 448 - 454
  • [47] EARLY DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION WITH SPECIAL REFERENCE TO DIAGNOSIS OF INTERMEDIATE CORONARY SYNDROME - CLINICAL STUDY
    SAWE, U
    ACTA MEDICA SCANDINAVICA, 1972, : 1 - +
  • [48] Usefulness of troponin I for predicting systolic dysfunction in acute coronary syndromes.: Results of a prospective and quantitative study
    Bodí, V
    Núñez, J
    Sanchis, J
    Llàcer, A
    Fácila, L
    Chorro, FJ
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (07): : 738 - 741
  • [49] Release of macromolecular cardiac troponin I complex after successful percultaneous transluminal coronary angioplasty in acute myocardial infarction
    Lavoinne, A
    Cauliez, B
    Eltchaninoff, H
    Tron, C
    Cribier, A
    CLINICAL CHEMISTRY, 2003, 49 (03) : 505 - 507
  • [50] Validation of a rapid diagnostic algorithm for diagnosis of myocardial infarction using a high-sensitivity cardiac troponin assay
    Lehmacher, J.
    Toprak, B.
    Soerensen, N. A.
    Kellen, R. Bei Der
    Hartikainen, T. S.
    Haller, P. M.
    Schock, A.
    Twerenbold, R.
    Zeller, T.
    Blankenberg, S.
    Westermann, D.
    Neumann, J. T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1355 - 1355